immunitoAI · Series A

Bengaluru-based biotech building an AI platform that designs novel antibody therapeutics from

Amount

$6.1M

Round

Series A

Valuation

—

Announced

—

Investors

Lead investor

Ashish Kacholia

Participating investors

3one4 Capital pi Ventures AC Ventures Anicut Capital JITO Incubation & Innovation Foundation